Fenfluramine

Fenfluramine

SCHEMBL39491

CCNC(C)Cc1cccc(C(F)(F)F)c1.Cl

nearest known ligand 0.97

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

HTR1DHTR2CSIGMAR1

The experimentally established mechanism targets of Fenfluramine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 known ✓ Q99720 4/20 0.97
HTR2C known ✓ P28335 4/20 0.62
HTR1D known ✓ P28221 1/20 0.45
SLC6A4 P31645 6/20 0.97
HTR2A P28223 4/20 0.97
HTR2B P41595 4/20 0.97
ADRA2C P18825 4/20 0.97
DRD3 P35462 4/20 0.97
ADRA1A P35348 2/20 0.97
OPRK1 P41145 2/20 0.97
LMNA P02545 1/20 0.97
MAPT P10636 1/20 0.97
CYP3A4 P08684 3/20 0.65
CYP2D6 P10635 3/20 0.65
CYP1A2 P05177 2/20 0.65
TP53 P04637 1/20 0.65
TSHR P16473 1/20 0.65
CYP2C19 P33261 1/20 0.65
USP2 O75604 2/20 0.58
SLC6A2 P23975 3/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fenfluramine SCHEMBL11140094 1.00 SLC6A4 (0.97) SLC6A4SIGMAR1HTR2AHTR2BADRA2C
Levofenfluramine SCHEMBL30951308 1.00 SLC6A4 (0.97) SLC6A4SIGMAR1HTR2AHTR2BADRA2C
Dexfenfluramine SCHEMBL29362838 1.00 SLC6A4 (0.97) SLC6A4SIGMAR1HTR2AHTR2BADRA2C
Fenfluramine SCHEMBL6276588 1.00 SLC6A4 (0.97) SLC6A4SIGMAR1HTR2AHTR2BADRA2C
Fenfluramine SCHEMBL9080932 1.00 SLC6A4 (0.97) SLC6A4SIGMAR1HTR2AHTR2BADRA2C
Fenfluramine SCHEMBL9276141 1.00 SLC6A4 (0.97) SLC6A4SIGMAR1HTR2AHTR2BADRA2C
Dexfenfluramine SCHEMBL120916 1.00 SLC6A4 (0.97) SLC6A4SIGMAR1HTR2AHTR2BADRA2C
Fenfluramine SCHEMBL10947502 0.98 SLC6A4 (0.94) SLC6A4SIGMAR1HTR2AHTR2BADRA2C
Fenfluramine SCHEMBL10602733 0.98 SLC6A4 (0.94) SLC6A4SIGMAR1HTR2AHTR2BADRA2C
Fenfluramine SCHEMBL20590765 0.98 SLC6A4 (0.94) SLC6A4SIGMAR1HTR2AHTR2BADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 38333 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250213547-A1 METHODS OF TREATING NEUROLOGICAL DISEASES TAKEDA PHARMACEUTICALS CO (JP) 2025-07-03 US claimed
EP-4293009-B1 FENFLURAMINE COMPOSITIONS AND METHODS OF PREPARING THE SAME ZOGENIX INTERNATIONAL LTD (GB) 2025-06-11 EP claimed
CN-119790152-A Treatment of neurological disorders using modulators of UNC13A gene transcripts 奎里斯公司 2025-04-08 CN claimed
CN-119522282-A Splice transducer antisense oligonucleotides with modified backbone chemistry 奎里斯公司 2025-02-25 CN claimed
CN-119452086-A GAPMER antisense oligonucleotides with modified backbone chemistry 奎里斯公司 2025-02-14 CN claimed
US-20250051766-A1 TREATMENT OF NEUROLOGICAL DISEASES USING MODULATORS OF UNC13A GENE TRANSCRIPTS QURALIS CORPORATION 2025-02-13 US claimed
US-20250032503-A1 USE OF APREPITANT FOR TREATING ALZHEIMER'S DISEASE HOTH THERAPEUTICS, INC. 2025-01-30 US claimed
EP-3800177-B1 FENFLURAMINE COMPOSITIONS AND METHODS OF PREPARING THE SAME ZOGENIX INTERNATIONAL LTD (GB) 2025-01-29 EP claimed
WO-2023102242-A9 SPLICE SWITCHER ANTISENSE OLIGONUCLEOTIDES WITH MODIFIED BACKBONE CHEMISTRIES QURALIS CORPORATION (US) 2024-10-31 WO claimed
US-20240343675-A1 AN IMPROVED PROCESS FOR THE PREPARATION OF N-ETHYL- A -METHYL-3-(TRIFLUOROMETHYL) PHENETHYLAMINE HYDROCHLORIDE BIOPHORE INDIA PHARMACEUTICALS PVT. LTD. (IN) 2024-10-17 US claimed
US-4187119-A Glue for articles in the tobacco industry SERVICE D'EXPLOITATION INDUSTRIELLE DES TABACS ET DES ALLUMETTES (FR) 1980-02-05 US claimed
EP-0006390-A1 Process of forming a fibrous web by the papermaking technique in order to improve the binding and retention, web obtained by this process and its use as a substitute material for asbestos products and as a printing or writing support ARJOMARI-PRIOUX S.A. (FR) 1980-01-09 EP claimed
US-4178465-A Processes for preparing perfluoropolyether oils of very high purity and low volatility MONTEDISON S.P.A. (IT) 1979-12-11 US claimed
EP-0004407-A2 Process for the production of peracids and their use for the preparation of epoxides from olefins PROPYLOX (Société Anonyme) (BE) 1979-10-03 EP claimed
EP-0004237-A1 Ion exchange membranes; their preparation and their use in the electrolysis of sodium chloride ELF ATOCHEM S.A. (FR) 1979-09-19 EP claimed
EP-0003932-A1 Saturated cross-linkable polyester compositions for a powder coating with a mat and/or glossy surface and process for preparing such a coating CdF CHIMIE RESINES (FR) 1979-09-05 EP claimed
EP-0003704-A1 Method of and apparatus for continuously mixing powdery solids and liquids, especially plaster with water SAINT-GOBAIN INDUSTRIES (FR) 1979-08-22 EP claimed
EP-0001859-A1 Rigid compositions based on polyvinyl chloride, heat stabilised with a mixture of magnesium oxide and a polyol SOLVAY & Cie (Société Anonyme) (BE) 1979-05-16 EP claimed
EP-0001196-A1 Device for the automatic control of a filling apparatus for receptacles S.E.R.A.C. GROUP (FR) 1979-03-21 EP claimed
EP-0001190-A1 Use of carboxymethylgalactomannangels as carriers in products for air-treatment C E C A S.A. (FR) 1979-03-21 EP claimed